{"id":12798,"date":"2025-08-26T12:10:05","date_gmt":"2025-08-26T10:10:05","guid":{"rendered":"https:\/\/www.kliinikum.ee\/yhendlabor\/?page_id=12798"},"modified":"2025-12-10T18:46:26","modified_gmt":"2025-12-10T16:46:26","slug":"anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg","status":"publish","type":"page","link":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\/","title":{"rendered":"Anaplasma phagocytophilumi vastased IgM ja IgG (S-A phagocytophilum IgM ja S-A phagocytophilum IgG)"},"content":{"rendered":"\n

Immuunanal\u00fc\u00fcsi osakond<\/em><\/p>\n\n\n\n

Anaplasma phagocytophilum<\/strong> (varasemalt tuntud kui Ehrlichia phagocytophilum) on obligatoorselt <\/em>intratsellulaarne bakter, mis p\u00f5hjustab granulots\u00fctaarset anaplasmoosi (HGA, human granulocytic anaplasmosis<\/em>).<\/p>\n\n\n\n

Anaplasma levib puugihammustusega, ent kirjeldatud on ka nakatumist vere\u00fclekandel.<\/p>\n\n\n\n

Anaplasmoosi peiteaeg on 1\u20132 n\u00e4dalat. Haiguse kliiniline pilt sarnaneb erlihhioosiga ning v\u00f5ib kulgeda v\u00e4ga erineva raskusastmega \u2013 as\u00fcmptomaatilisest nakatumisest v\u00f5i subkliinilistest n\u00e4htudest kuni \u00e4geda hospitaliseerimist vajava haigestumiseni. Raskemal haigestumisel v\u00f5ib avalduda gripisarnane s\u00fcmptomaatika, l\u00f6\u00f6ve v\u00f5i neuroloogilised n\u00e4hud.<\/p>\n\n\n\n

Antikehad muutuvad m\u00e4\u00e4ratavaks 1\u20134 n\u00e4dala jooksul p\u00e4rast nakatumist. Antikehad ei pruugi veres p\u00fcsida \u00fcle aasta. Antibakteriaalne ravi v\u00f5ib p\u00e4rssida antikehade teket.<\/p>\n\n\n\n

Uuritav materjal, selle v\u00f5tmine, saatmine ja s\u00e4ilitamine<\/strong><\/p>\n\n\n\n

<\/td>Proovin\u00f5u<\/strong><\/td>Geeli ja h\u00fc\u00fcbimisaktivaatoriga katsuti (punane kork kollase r\u00f5ngaga v\u00f5i kollane kork)<\/td><\/tr>
<\/td>S\u00e4ilivus<\/strong><\/td>Seerum +4 \u00b0C seitse p\u00e4eva<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Anal\u00fc\u00fcsi tegemise aeg:<\/strong> vajadusel<\/p>\n\n\n\n

Anal\u00fc\u00fcsimeetod:<\/strong> immunoblot<\/em>-meetod<\/p>\n\n\n\n

Vastuse vorm<\/strong><\/p>\n\n\n\n

Positiivne\/negatiivne\/piiripealne<\/p>\n\n\n\n

N\u00e4idustus ja kliiniline t\u00e4hendus<\/strong><\/p>\n\n\n\n

Kahtlus anaplasmoosile.<\/p>\n\n\n\n

IgM ja IgG samaaegne positiivne tulemus viitab hiljutisele nakatumisele. Ainult IgG t\u00fc\u00fcpi antikehade leid on iseloomulik l\u00e4bip\u00f5etud infektsioonile. Kui positiivsed on ainult IgM t\u00fc\u00fcpi antikehad, siis tuleb IgG tekke kontrollimiseks ja diagnoosi kinnitamiseks v\u00f5tta kordusanal\u00fc\u00fcs 2\u20134 n\u00e4dala p\u00e4rast. Negatiivse ja piiripealse tulemuse korral ja haiguse kahtluse p\u00fcsimisel korrata antikehade m\u00e4\u00e4ramist 2\u20134 n\u00e4dala p\u00e4rast.<\/p>\n\n\n\n

Koostajad: Anne Must, Raili Randoja
Muudetud 19.06.2024<\/p>\n","protected":false},"excerpt":{"rendered":"

Immuunanal\u00fc\u00fcsi osakond Anaplasma phagocytophilum (varasemalt tuntud kui Ehrlichia phagocytophilum) on obligatoorselt intratsellulaarne bakter, mis p\u00f5hjustab granulots\u00fctaarset anaplasmoosi (HGA, human granulocytic anaplasmosis). Anaplasma levib puugihammustusega, ent kirjeldatud on ka nakatumist vere\u00fclekandel. Anaplasmoosi peiteaeg on 1\u20132 n\u00e4dalat. Haiguse kliiniline pilt sarnaneb erlihhioosiga ning v\u00f5ib kulgeda v\u00e4ga erineva raskusastmega \u2013 as\u00fcmptomaatilisest nakatumisest v\u00f5i subkliinilistest n\u00e4htudest kuni \u00e4geda hospitaliseerimist […]<\/p>\n","protected":false},"author":38,"featured_media":0,"parent":7295,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_uag_custom_page_level_css":"","footnotes":""},"class_list":["post-12798","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nAnaplasma phagocytophilumi vastased IgM ja IgG (S-A phagocytophilum IgM ja S-A phagocytophilum IgG) - \u00dchendlabor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anaplasma phagocytophilumi vastased IgM ja IgG (S-A phagocytophilum IgM ja S-A phagocytophilum IgG) - \u00dchendlabor\" \/>\n<meta property=\"og:description\" content=\"Immuunanal\u00fc\u00fcsi osakond Anaplasma phagocytophilum (varasemalt tuntud kui Ehrlichia phagocytophilum) on obligatoorselt intratsellulaarne bakter, mis p\u00f5hjustab granulots\u00fctaarset anaplasmoosi (HGA, human granulocytic anaplasmosis). Anaplasma levib puugihammustusega, ent kirjeldatud on ka nakatumist vere\u00fclekandel. Anaplasmoosi peiteaeg on 1\u20132 n\u00e4dalat. Haiguse kliiniline pilt sarnaneb erlihhioosiga ning v\u00f5ib kulgeda v\u00e4ga erineva raskusastmega \u2013 as\u00fcmptomaatilisest nakatumisest v\u00f5i subkliinilistest n\u00e4htudest kuni \u00e4geda hospitaliseerimist […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\/\" \/>\n<meta property=\"og:site_name\" content=\"\u00dchendlabor\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-10T16:46:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\\\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\\\/\",\"url\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\\\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\\\/\",\"name\":\"Anaplasma phagocytophilumi vastased IgM ja IgG (S-A phagocytophilum IgM ja S-A phagocytophilum IgG) - \u00dchendlabor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/#website\"},\"datePublished\":\"2025-08-26T10:10:05+00:00\",\"dateModified\":\"2025-12-10T16:46:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\\\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\\\/#breadcrumb\"},\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\\\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\\\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"K\u00e4siraamat\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nakkustekitajate uuringud (DNA\\\/RNA, antikehad, antigeenid)\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Anaplasma phagocytophilumi vastased IgM ja IgG (S-A phagocytophilum IgM ja S-A phagocytophilum IgG)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/#website\",\"url\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/\",\"name\":\"\u00dchendlabor\",\"description\":\"Hoolivus, Uuendusmeelsus, P\u00e4devus ja Usaldusv\u00e4\u00e4rsus\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anaplasma phagocytophilumi vastased IgM ja IgG (S-A phagocytophilum IgM ja S-A phagocytophilum IgG) - \u00dchendlabor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\/","og_locale":"et_EE","og_type":"article","og_title":"Anaplasma phagocytophilumi vastased IgM ja IgG (S-A phagocytophilum IgM ja S-A phagocytophilum IgG) - \u00dchendlabor","og_description":"Immuunanal\u00fc\u00fcsi osakond Anaplasma phagocytophilum (varasemalt tuntud kui Ehrlichia phagocytophilum) on obligatoorselt intratsellulaarne bakter, mis p\u00f5hjustab granulots\u00fctaarset anaplasmoosi (HGA, human granulocytic anaplasmosis). Anaplasma levib puugihammustusega, ent kirjeldatud on ka nakatumist vere\u00fclekandel. Anaplasmoosi peiteaeg on 1\u20132 n\u00e4dalat. Haiguse kliiniline pilt sarnaneb erlihhioosiga ning v\u00f5ib kulgeda v\u00e4ga erineva raskusastmega \u2013 as\u00fcmptomaatilisest nakatumisest v\u00f5i subkliinilistest n\u00e4htudest kuni \u00e4geda hospitaliseerimist […]","og_url":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\/","og_site_name":"\u00dchendlabor","article_modified_time":"2025-12-10T16:46:26+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\/","url":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\/","name":"Anaplasma phagocytophilumi vastased IgM ja IgG (S-A phagocytophilum IgM ja S-A phagocytophilum IgG) - \u00dchendlabor","isPartOf":{"@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/#website"},"datePublished":"2025-08-26T10:10:05+00:00","dateModified":"2025-12-10T16:46:26+00:00","breadcrumb":{"@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\/#breadcrumb"},"inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\/anaplasma-phagocytophilumi-vastased-igm-ja-igg-s-a-phagocytophilum-igm-ja-s-a-phagocytophilum-igg\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/"},{"@type":"ListItem","position":2,"name":"K\u00e4siraamat","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/"},{"@type":"ListItem","position":3,"name":"Nakkustekitajate uuringud (DNA\/RNA, antikehad, antigeenid)","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/nakkustekitajate-uuringud-dna-rna-antikehad-antigeenid\/"},{"@type":"ListItem","position":4,"name":"Anaplasma phagocytophilumi vastased IgM ja IgG (S-A phagocytophilum IgM ja S-A phagocytophilum IgG)"}]},{"@type":"WebSite","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/#website","url":"https:\/\/www.kliinikum.ee\/yhendlabor\/","name":"\u00dchendlabor","description":"Hoolivus, Uuendusmeelsus, P\u00e4devus ja Usaldusv\u00e4\u00e4rsus","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kliinikum.ee\/yhendlabor\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false},"uagb_author_info":{"display_name":"Kadi Siigur","author_link":"https:\/\/www.kliinikum.ee\/yhendlabor\/author\/kadisi\/"},"uagb_comment_info":0,"uagb_excerpt":"Immuunanal\u00fc\u00fcsi osakond Anaplasma phagocytophilum (varasemalt tuntud kui Ehrlichia phagocytophilum) on obligatoorselt intratsellulaarne bakter, mis p\u00f5hjustab granulots\u00fctaarset anaplasmoosi (HGA, human granulocytic anaplasmosis). Anaplasma levib puugihammustusega, ent kirjeldatud on ka nakatumist vere\u00fclekandel. Anaplasmoosi peiteaeg on 1\u20132 n\u00e4dalat. Haiguse kliiniline pilt sarnaneb erlihhioosiga ning v\u00f5ib kulgeda v\u00e4ga erineva raskusastmega \u2013 as\u00fcmptomaatilisest nakatumisest v\u00f5i subkliinilistest n\u00e4htudest kuni \u00e4geda hospitaliseerimist…","_links":{"self":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/12798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/comments?post=12798"}],"version-history":[{"count":0,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/12798\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/7295"}],"wp:attachment":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/media?parent=12798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}